TYRO Protein Tyrosine Kinase-Binding Protein (TYROBP) Peptide

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
TYRO Protein Tyrosine Kinase-Binding Protein (TYROBP) Peptide is a synthetic peptide.
Documents del producto
Product specifications
Category | Proteins and Peptides |
Immunogen Target | TYRO Protein Tyrosine Kinase-Binding Protein (TYROBP) |
Host | Synthetic |
Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Observed MW | Sequence Fragment: C-KQRITETESPYQE |
Size 1 | 100 µg |
Form | Lyophilized Reconstitute in deionized water. |
Tested Applications | P-ELISA |
Buffer | Prior to lyophilization: Deionized water. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Gene ID | 7305 |
NCBI Accession | NP_003323.1, NP_937758.1 |
Background | Protein TYROBP |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Human TYROBP (TYRO protein tyrosine kinase-binding protein) ELISA Kit
Ver Producto
Human TYROBP (TYRO protein tyrosine kinase-binding protein) QuickTest ELISA Kit
Ver Producto
TYRO Protein Tyrosine Kinase Binding Protein (TYROBP) Antibody
TYROBP Antibody is a Rabbit Polyclonal antibody against TYROBP. This gene encodes a transmembrane signaling polypeptide which contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain. The encoded protein may associate with the killer-cell inhibitory receptor (KIR) family of membrane glycoproteins and may act as an activating signal transduction element. This protein may bind zeta-chain (TCR) associated protein kinase 70kDa (ZAP-70) and spleen tyrosine kinase (SYK) and play a role in signal transduction, bone modeling, brain myelination, and inflammation. Mutations within this gene have been associated with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. Its putative receptor, triggering receptor expressed on myeloid cells 2 (TREM2), also causes PLOSL. Multiple alternative transcript variants encoding distinct isoforms have been identified for this gene.
Ver Producto